Penticton's Newest Master-Planned Community: The Innovation District

Introducing Penticton’s Newest Master-Planned Community: The Innovation District by Stryke Group

December 20, 2023

William Wright Commercial is thrilled to announce that we have been chosen by Stryke Group and Tien Sher Group to represent their commercial real estate needs for the Innovation District, a 10-acre master-planned community at 1704 Government Road in Penticton, BC.

The project will be anchored by over 100,000 SQFT of pedestrian focused retail, medical professional office space, and strata opportunities for businesses looking to be a part of this generational development. The site is strategically located across from the Penticton General Hospital ($300 million expansion completed in November 2021) and will ultimately service 1,500 new homes on the site and truly transform the Penticton landscape.

A special thank you to Rocky Sethi, Charan Sethi, Bob Shoker, Deep Dhillon, and all the strategic partners who will bring this vision to life!

William Wright Commercial will have our booth at ICSC in Whistler from January 21–23, 2024 and we look forward to meeting with anyone interested in learning more about the multi-phased development.

For further information on sale and lease opportunities in 2024, please contact the Kelowna office:

Jeff Brown
[email protected]

Nick Renton
[email protected]

Victoria Mitchell
[email protected]

Jeff Hancock*
[email protected]

Shelby Kostyshen
[email protected]

Kelowna Office
205-478 Bernard Avenue, Kelowna

Related News

More Stories

This communication is not intended to cause or induce breach of an existing agency agreement. E&OE: All information contained herein is from sources deemed reliable, and have no reason to doubt its accuracy; however, no guarantee or responsibility is assumed thereof, and it shall not form any part of future contracts. Properties are submitted subject to errors and omissions and all information should be carefully verified. All measurements quoted herein are approximate.